Gain Therapeutics says cash runway extends into Q2 2027 amid Phase 2 start plans
Gain Therapeutics announced its cash and cash equivalents are expected to fund operations into the second quarter of 2027.Key Highlights:Original SEC Filing: Gain Therapeutics, Inc. [ GANX ] - 8-K - Jul. 16, 2026This is an AI-powered summary. It may contain inaccuracies. Consider verifying importan…